Actively Recruiting

Age: 30Months - 11Years
All Genders
NCT07301463

A Study in Children With Achondroplasia

Led by Abbisko Therapeutics Co, Ltd · Updated on 2025-12-24

260

Participants Needed

8

Research Sites

723 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this observational study is to collect the anthropometric parameters, clinical characteristics, related medical complications, health-related quality of life and treatments of children with ACH, and complete a natural history observation of ACH for at least 6 months and up to 2 years.

CONDITIONS

Official Title

A Study in Children With Achondroplasia

Who Can Participate

Age: 30Months - 11Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Guardians and children with ACH must be willing and able to provide signed informed consent prior to screening
  • Clinical diagnosis of ACH confirmed by FGFR3 mutation genetic testing
  • Male or female aged 2.5 months to under 11 years at screening
  • Tanner Stage 1 breast development for females or Tanner Stage 1 external genitalia development for males at screening
  • Ambulatory and able to stand without assistance
Not Eligible

You will not qualify if you...

  • Bone age 14 years or older based on hand and wrist X-ray within 6 months prior to Day 1
  • Evidence of growth plate closure in proximal tibia or distal femur, or annualized growth velocity 1.5 cm/year or less over at least 6 months prior to screening
  • Skeletal dysplasia other than ACH or medical conditions causing short stature or abnormal growth, including severe achondroplasia with developmental delay and acanthosis nigricans, Turner syndrome, pseudoachondroplasia, inflammatory bowel disease, chronic renal insufficiency, active celiac disease (except if responsive to gluten-free diet), vitamin D deficiency or insufficiency not corrected by supplementation, untreated hypothyroidism, poorly controlled diabetes, or diabetic complications
  • History or presence of injury or disease affecting growth plates other than ACH
  • Impaired cardiac function or significant cardiovascular disease, including NYHA class II or higher, certain congenital heart diseases, significant arrhythmias, aortic regurgitation, congestive heart failure, or other uncontrolled heart disease
  • Current severe sleep apnea, symptomatic or requiring intervention for hydrocephalus, spinal cord compression at cranio-cervical junction, or previous ventriculoperitoneal shunt surgery
  • Bone fracture within 6 months prior to screening (2 months for finger and toe fractures)
  • Use of medications affecting stature or body proportionality like human growth hormone, IGF-1, or anabolic steroids within 3 months prior to screening or long-term use exceeding 3 months
  • Prior treatment with CNP analogues, FGFR inhibitors, or investigational drugs or devices affecting stature or body proportionality
  • Any comorbidities or conditions likely to prevent full study participation or protocol compliance as judged by the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 8 locations

1

Beijing Children's Hospital, Capital Medical University

Beijing, Beijing Municipality, China

Actively Recruiting

2

Guangzhou Women and Childrens Medical Center

Guangzhou, Guangzhou, China

Not Yet Recruiting

3

Henan Children's Hospital, Zhengzhou Children's Hospital

Zhengzhou, Henan, China

Not Yet Recruiting

4

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, China

Actively Recruiting

5

Xin Hua Hospital Affiliatod to Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, China

Actively Recruiting

6

Chengdu Women's and Children's Central Hospital

Chengdu, Sichuan, China

Not Yet Recruiting

7

West China Second University Hospital, Sichuan University

Chengdu, Sichuan, China

Active, Not Recruiting

8

Children's Hospital Zhejiang University School of Medicine

Hangzhou, Zhejiang, China

Not Yet Recruiting

Loading map...

Research Team

J

Jing Zhang

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here